These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1247959)

  • 1. Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horn NL; Ray GR; Kriss JP
    Cancer; 1976 Jan; 37(1):250-7. PubMed ID: 1247959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium-67-citrate scanning for the localization and staging of lymphomas.
    Adler S; Parthasarathy KL; Bakshi SP; Stutzman L
    J Nucl Med; 1975 Apr; 16(4):255-60. PubMed ID: 1089769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of gallium-67 scanning in upper abdominal lymphomas.
    Andrews JT; Sullivan JR; McKay WJ; Hurley TH
    Med J Aust; 1976 Jul; 2(5):170-2. PubMed ID: 989882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 67gallium citrate scanning in the management of non-Hodgkin's lymphoma.
    Levi JA; O'Connell MJ; Murphy WL; Sutherland JC; Wiernik PH
    Cancer; 1975 Nov; 36(5):1690-741. PubMed ID: 1104139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide studies in Hodgkin's disease and lymphomas.
    Richman SD; Levenson SM; Jones AE; Johnston GS
    Semin Nucl Med; 1975 Jan; 5(1):103-8. PubMed ID: 47183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of gallium-67 in malignant lymphoma.
    Makoski HB; Teske HJ; Becker G
    Acta Radiol Ther Phys Biol; 1976 Aug; 15(4):321-8. PubMed ID: 983781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Localization of Hodgkin's disease and non-Hodgkin lymphoma by means of 67 gallium subtraction scintigraphy].
    Krolikiewicz H; Maruyama Y; Deland FH; Beihn RM; Hafner T; Utley JF
    Onkologie; 1978 Feb; 1(1):24-30. PubMed ID: 362278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of retroperitoneal ultrasonography in Hodgkin's disease and non-Hodgkin's lymphoma.
    Brascho DJ; Durant JR; Green LE
    Radiology; 1977 Nov; 125(2):485-7. PubMed ID: 910062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose gallium imaging in lymphoma.
    Anderson KC; Leonard RC; Canellos GP; Skarin AT; Kaplan WD
    Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphic evaluation of lymphoma: a comparative study of 67Ga-citrate and 111In-Bleomycin.
    Bekerman C; Moran EM; Hoffer PB; Hendrix RW; Gottschalk A
    Radiology; 1977 Jun; 123(3):687-94. PubMed ID: 860022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphoma.
    Rudders RA; McCaffrey JA; Kahn PC
    Cancer; 1977 Oct; 40(4):1439-43. PubMed ID: 907962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after the treatment of Hodgkin's disease.
    Lee JD; Park CH; Griffith J; Vernick J
    J Nucl Med; 1992 Jun; 33(6):1183-5. PubMed ID: 1597736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body radiogallium scanning for staging of Hodgkin's disease and other lymphomas.
    Hoffer PB; Turner D; Gottschalk A; Harper PV; Ultmann JE
    Natl Cancer Inst Monogr; 1973 May; 36():277-85. PubMed ID: 4744586
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive spleen scanning in Hodgkin's disease and non-Hodgkin's lymphoma.
    Frick MP; Feinberg SB; Loken MK
    Comput Tomogr; 1981; 5(1):73-80. PubMed ID: 7249618
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent lymphoma detected on F-18 FDG coincidence imaging with negative findings on Ga-67 citrate scintigraphy.
    Ojha B; Bender LW; Francisco R; Scott JW
    Clin Nucl Med; 2002 Sep; 27(9):638-40. PubMed ID: 12192281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.